The Efficacy of the IGel Supraglottic Airway in Cardiac Arrest Patients

The Efficacy of the IGel Supraglottic Airway in Cardiac Arrest Patients

The Efficacy of the IGel Supraglottic Airway in Cardiac Arrest Patients


Effective airway management is a critical component of successful cardiopulmonary resuscitation (CPR) during cardiac arrest. Traditional endotracheal intubation (ETI) has long been considered the gold standard for airway management in these cases. And, while ETI has shown better outcomes in both medical and trauma arrest in numerous studies, the procedure can be challenging, time-consuming, and associated with potential complications, especially in the hands of less experienced personnel. The IGel supraglottic airway device (SAD) has emerged as a promising alternative for initial airway management in cardiac arrest situations, offering several advantages over immediate use of ETI.


1. Ease of Insertion:
The IGel SAD is designed for rapid and easy insertion, even by providers with limited experience in advanced airway management. Unlike ETI, the IGel does not require visualization of the vocal cords or precise positioning, reducing the potential for complications and minimizing interruptions in chest compressions during CPR. This feature is particularly valuable in the context of cardiac arrest, where time is of the essence, and minimizing interruptions in CPR is crucial for improving patient outcomes.

2. Improved Ventilation:
Several studies have demonstrated that the IGel SAD provides effective ventilation and oxygenation in cardiac arrest patients. A study by Benger et al. compared the IGel to other SADs and found comparable or superior ventilation performance. Furthermore, the IGel's unique non-inflatable cuff design reduces the risk of airway trauma and potential complications associated with cuff overinflation or displacement.

3. Enhanced CPR Quality:
The use of the IGel SAD has been shown to improve the quality of CPR by reducing the frequency and duration of interruptions for airway management. Uninterrupted, high-quality CPR is essential for maintaining adequate perfusion and improving the chances of successful resuscitation. By minimizing interruptions, the IGel can contribute to better CPR quality and potentially improved patient outcomes.

4. Improved Success Rates:
Several studies have reported higher success rates for the IGel SAD compared to other airway management techniques, including ETI, in cardiac arrest situations. A systematic review and meta-analysis by Naiman et al. found that the IGel had a higher overall success rate and a shorter time to successful insertion compared to ETI in out-of-hospital cardiac arrest (OHCA) patients.

5. Reduced Complications:
The use of the IGel SAD has been associated with a lower risk of complications compared to ETI. These complications can include dental or airway trauma, aspiration, and failed intubation attempts, which can be particularly detrimental in cardiac arrest situations. The IGel's design and ease of insertion minimize the potential for these complications, making it a safer alternative for airway management during CPR.


The IGel supraglottic airway device offers several advantages over traditional endotracheal intubation in the context of cardiac arrest resuscitation. Its ease of insertion, effective ventilation performance, potential for improved CPR quality, higher success rates, and lower risk of complications make it a valuable tool for airway management in these critical situations. While ETI remains an important skill for highly trained healthcare providers and increases survival in some patient populations, the IGel provides a viable alternative, particularly in settings where advanced airway management expertise may be limited or when rapid airway establishment is crucial. Continued research and training in the use of the IGel can contribute to improved outcomes for cardiac arrest patients.



1.      Bhandari G, Shahi KS, Asad M, Parmar NK, Bhakuni R. To assess the efficacy of i-gel for ventilation, blind tracheal intubation and nasogastric tube insertion. Anesth Essays Res. 2013 Jan-Apr;7(1):94-9. doi: 10.4103/0259-1162.114012. PMID: 25885728; PMCID: PMC4173497.

2.      Benger J, Coates D, Davies S, Greenwood R, Nolan J, Rhys M, Thomas M, Voss S. Randomised comparison of the effectiveness of the laryngeal mask airway supreme, i-gel and current practice in the initial airway management of out of hospital cardiac arrest: a feasibility study. Br J Anaesth. 2016 Feb;116(2):262-8. doi: 10.1093/bja/aev477. PMID: 26787796.

3.      Theiler LG, Kleine-Brueggeney M, Kaiser D, Urwyler N, Luyet C, Vogt A, Greif R, Unibe MM. Crossover comparison of the laryngeal mask supreme and the i-gel in simulated difficult airway scenario in anesthetized patients. Anesthesiology. 2009 Jul;111(1):55-62. doi: 10.1097/ALN.0b013e3181a4c6b9. PMID: 19512881.

4.      Liti A, Giusti GD, Gili A, Giontella M, Dell'Omo S, Camerlingo V, Fronteddu A, Galazzi A, Bambi S. Insertion of four different types of supraglottic airway devices by emergency nurses. A mannequin-based simulation study. Acta Biomed. 2020 Nov 30;91(12-S):e2020016. doi: 10.23750/abm.v91i12-S.10832. PMID: 33263351; PMCID: PMC8023114.

5.      Forestell B, Ramsden S, Sharif S, Centofanti J, Al Lawati K, Fernando SM, Welsford M, Nichol G, Nolan JP, Rochwerg B. Supraglottic Airway Versus Tracheal Intubation for Airway Management in Out-of-Hospital Cardiac Arrest: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials. Crit Care Med. 2024 Feb 1;52(2):e89-e99. doi: 10.1097/CCM.0000000000006112. Epub 2023 Nov 13. PMID: 37962112.

6.      Häske D, Schempf B, Gaier G, Niederberger C. Performance of the i-gel™ during pre-hospital cardiopulmonary resuscitation. Resuscitation. 2013 Sep;84(9):1229-32. doi: 10.1016/j.resuscitation.2013.04.025. Epub 2013 May 4. PMID: 23648215.

Related topics: advanced practice (7) | competence (8) | cortical care (3) | critical care (14) | Nurses (7) | paramedic (12) | Physicians (10) | sedation (2)

Recent blogs: